The effect of low-dose epsilon-aminocaproic acid on patients following coronary artery bypass surgery

Abstract

The effect of low-dose epsilon-aminocaproic acid (EACA) on the postoperative course of 46 patients was studied. Patients undergoing coronary artery bypass grafting were randomly selected in two groups. Group 1 (20 patients) received 5 g EACA upon initiation of cardiopulmonary bypass (CPB). Group 2 (26 patients) received no antifibrinolytic drugs prior to CPB. Neither group received antifibrinolytic drugs after CPB. There was no significant difference between the two groups' blood usage on CPB: 0.65 units in Group 1 and 0.60 units in Group 2. After CPB, blood usage significantly differed: 2.2 ± 1.7 (SD) units in Group 1 and 3.9 ± 3.0 units in Group 2 (p = 0.033). Significant difference was also demonstrated in postoperative blood loss in the first 24 hours: 1610 ± 531 ml in Group 1 versus 2025 ± 804 ml in Group 2 (p = 0.043). Pre-CPB administration of low-dose EACA significantly decreases blood loss and blood usage in the postoperative period.

Get full access to this article

View all access options for this article.

References

Speiss BD

The contribution of fibrinolysis to postbypass bleeding

J Cardiothorac Vasc Anesth 1991; 5(suppl 1): 13-17.

Arom KV , Emery RW

Decreased postoperative drainage with addition of ∈-aminocaproic acid before cardiopulmonary bypass

Ann Thorac Surg 1994; 57: 1108-13.

Hardy JF , Desroches J.

Natural and synthetic antifibrinolytics in cardiac surgery

Can J Anaesth 1992; 39 : 353-65.

Horrow JC , Van Riper DF , Strong MD , Brodsky I. , Parmet JL

Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery

Circulation 1991;84:2063-70

DelRossi AJ , Cernaianu AC , Botros S. , Lemole GM , Moore R.

Prophylactic treatment of postperfusion bleeding using EACA

Chest 1989; 96 : 27-30.

Holloway DS , Summaria L. , Sandesara J. , Vagher JP , Alexander JC , Caprini JA

Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients

Thromb Haemostat 1988; 59 : 62-67.

Vander Salm TJ , Ansell JE , Okike ON et al.

The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study

J Thorac Cardiovasc Surg 1988 ; 95: 538-40.

Lambert CJ , Marengo-Rowe AJ , Leveson JE et al.

The treatment of postperfusion bleeding using ∈-aminocaproic acid, cryoprecipitate, fresh-frozen plasma and protamine sulfate

Ann Thorac Surg 1979; 28 : 440-44.

Horrow JC , Hlavacek J. , Strong MD et al.

Prophylactic tranexamic acid decreases bleeding after cardiac operations

J Thorac Cardiovasc Surg 1990; 99: 70-74.

10.

Soslau G. , Horrow J. , Brodsky I.

Effect of tranexamic acid on platelet ADP during extracorporeal circulation

Am J Hematology 1991; 38: 113-19.

11.

Jones RE , Cohn LH

Prophylaxis for post-perfusion CABG bleeding [Letter]

Chest 1990; 98: 516.